A Case of Refractory Sézary Syndrome With Large-Cell Transformation Responsive to Brentuximab Vedotin

JAMA Dermatology - United States
doi 10.1001/jamadermatol.2013.5741
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy